Los Angeles, CA
Boundless Bio, a San Diego based company backed by ARCH Venture Partners, is discovering and developing novel cancer therapeutics based on the role of extrachromosomal DNA (ecDNA) in driving tumorigenesis, resistance and recurrence.
boundlessbio.comThese are collections Boundless Bio is a part of. Click on the collection name to view similar companies.
IPO
Unknown
Series C
$100,000,000
Series B
$105,000,000
Series A
$46,400,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Boundless Bio.